2013
DOI: 10.1051/medsci/20132910012
|View full text |Cite
|
Sign up to set email alerts
|

Structure du récepteur Smoothened

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 33 publications
0
3
0
1
Order By: Relevance
“…SMO is a major component involved in SHH signaling transduction, which can be coupled with G protein‐coupled receptors (GPCRs) to inhibit the activity of suppressor of fused protein (SUFU) and GLI family of transcription factors. When the SHH signaling pathway is activated, PTCH‐1 , which destabilizes SMO and inhibits its activity, is degraded, leading to the activation of G‐protein coupled receptor (GPCR)/ SMO activity 25 . This promotes the dissociation of GLI from its inhibitor protein SUFU, resulting in the release and transport of GLI into the nucleus, triggering downstream target gene expression and activating cellular functions 26 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…SMO is a major component involved in SHH signaling transduction, which can be coupled with G protein‐coupled receptors (GPCRs) to inhibit the activity of suppressor of fused protein (SUFU) and GLI family of transcription factors. When the SHH signaling pathway is activated, PTCH‐1 , which destabilizes SMO and inhibits its activity, is degraded, leading to the activation of G‐protein coupled receptor (GPCR)/ SMO activity 25 . This promotes the dissociation of GLI from its inhibitor protein SUFU, resulting in the release and transport of GLI into the nucleus, triggering downstream target gene expression and activating cellular functions 26 .…”
Section: Discussionmentioning
confidence: 99%
“…When the SHH signaling pathway is activated, PTCH‐1 , which destabilizes SMO and inhibits its activity, is degraded, leading to the activation of G‐protein coupled receptor (GPCR)/ SMO activity. 25 This promotes the dissociation of GLI from its inhibitor protein SUFU, resulting in the release and transport of GLI into the nucleus, triggering downstream target gene expression and activating cellular functions. 26 However, our results revealed a significant decrease in SMO and GLI‐1 protein levels in tumor tissues, suggesting that Rab23 plays a negative regulatory role in the SHH signaling pathway and can suppress tumor growth in HCC.…”
Section: Discussionmentioning
confidence: 99%
“…C'est pourquoi nous venons d'invalider in vivo dans les CSN adultes la protéine membranaire Patched, suppresseur de tumeurs et récepteur de Shh [9]. En l'absence de Shh, Patched réprime l'activité de Smoothened, l'élément clé de la transmission du signal Shh et une cible thérapeutique potentielle [10,11]. Si Patched n'est plus fonctionnel, la répression qu'il exerce normalement sur Smoothened est levée, ce qui conduit à l'activation endogène de la voie et à l'induction de la transcription du gène cible Gli1 dont le niveau d'expression reflète l'activité de la voie ( Figure 1A [6,16].…”
Section: Sonic Hedgehog Contrôle Le Devenir Des Csnunclassified
“…Hedgehog interacting protein (HHIP) binds to IHH, DHH and SHH to inhibit HH signaling pathway [25-27]. The upregulation of HH signaling pathway is associated with decreasing expression of HHIP in human cancers [28-30].…”
Section: Introductionmentioning
confidence: 99%